The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Animal Drugs Market Research Report 2024
Synopsis
An animal drug (also veterinary drug) refers to a drug intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in animals.
The global Animal Drugs market was valued at US$ 23520 million in 2023 and is anticipated to reach US$ 33280 million by 2030, witnessing a CAGR of 5.1% during the forecast period 2024-2030.
The animal drugs market is projected to experience significant growth in the foreseeable future. Factors such as increasing pet ownership, growing demand for livestock products, and the prevalence of animal diseases drive market growth. The market is highly competitive, with several pharmaceutical companies involved in the production and distribution of animal drugs. However, challenges such as stringent regulatory requirements, concerns about antibiotic resistance, and limited accessibility in developing regions may hinder market expansion. Nonetheless, the animal drugs market holds promising opportunities, fueled by the need for effective treatments and preventive measures for animal health, and the growing focus on animal welfare and food safety.
This report aims to provide a comprehensive presentation of the global market for Animal Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Drugs.
Report Scope
The Animal Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Animal Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Animal Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Boehringer Ingelheim
Merck Animal Health
Elanco
Bayer Animal Health
Ceva Animal Health
Virbac
Dechra
Phibro
Vetoquinol
Ouro Fino Saude
Segment by Type
Anti-infective
Anti-inflammatory
Parasiticides
Other
Segment by Application
Livestock
Companion
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Animal Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
An animal drug (also veterinary drug) refers to a drug intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in animals.
The global Animal Drugs market was valued at US$ 23520 million in 2023 and is anticipated to reach US$ 33280 million by 2030, witnessing a CAGR of 5.1% during the forecast period 2024-2030.
The animal drugs market is projected to experience significant growth in the foreseeable future. Factors such as increasing pet ownership, growing demand for livestock products, and the prevalence of animal diseases drive market growth. The market is highly competitive, with several pharmaceutical companies involved in the production and distribution of animal drugs. However, challenges such as stringent regulatory requirements, concerns about antibiotic resistance, and limited accessibility in developing regions may hinder market expansion. Nonetheless, the animal drugs market holds promising opportunities, fueled by the need for effective treatments and preventive measures for animal health, and the growing focus on animal welfare and food safety.
This report aims to provide a comprehensive presentation of the global market for Animal Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Drugs.
Report Scope
The Animal Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Animal Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Animal Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Boehringer Ingelheim
Merck Animal Health
Elanco
Bayer Animal Health
Ceva Animal Health
Virbac
Dechra
Phibro
Vetoquinol
Ouro Fino Saude
Segment by Type
Anti-infective
Anti-inflammatory
Parasiticides
Other
Segment by Application
Livestock
Companion
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Animal Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Animal Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Anti-infective
1.2.3 Anti-inflammatory
1.2.4 Parasiticides
1.2.5 Other
1.3 Market by Application
1.3.1 Global Animal Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Livestock
1.3.3 Companion
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Animal Drugs Market Perspective (2019-2030)
2.2 Animal Drugs Growth Trends by Region
2.2.1 Global Animal Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Animal Drugs Historic Market Size by Region (2019-2024)
2.2.3 Animal Drugs Forecasted Market Size by Region (2025-2030)
2.3 Animal Drugs Market Dynamics
2.3.1 Animal Drugs Industry Trends
2.3.2 Animal Drugs Market Drivers
2.3.3 Animal Drugs Market Challenges
2.3.4 Animal Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Animal Drugs Players by Revenue
3.1.1 Global Top Animal Drugs Players by Revenue (2019-2024)
3.1.2 Global Animal Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Animal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Animal Drugs Revenue
3.4 Global Animal Drugs Market Concentration Ratio
3.4.1 Global Animal Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Animal Drugs Revenue in 2023
3.5 Animal Drugs Key Players Head office and Area Served
3.6 Key Players Animal Drugs Product Solution and Service
3.7 Date of Enter into Animal Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Animal Drugs Breakdown Data by Type
4.1 Global Animal Drugs Historic Market Size by Type (2019-2024)
4.2 Global Animal Drugs Forecasted Market Size by Type (2025-2030)
5 Animal Drugs Breakdown Data by Application
5.1 Global Animal Drugs Historic Market Size by Application (2019-2024)
5.2 Global Animal Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Animal Drugs Market Size (2019-2030)
6.2 North America Animal Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Animal Drugs Market Size by Country (2019-2024)
6.4 North America Animal Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Animal Drugs Market Size (2019-2030)
7.2 Europe Animal Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Animal Drugs Market Size by Country (2019-2024)
7.4 Europe Animal Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Animal Drugs Market Size (2019-2030)
8.2 Asia-Pacific Animal Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Animal Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Animal Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Animal Drugs Market Size (2019-2030)
9.2 Latin America Animal Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Animal Drugs Market Size by Country (2019-2024)
9.4 Latin America Animal Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Animal Drugs Market Size (2019-2030)
10.2 Middle East & Africa Animal Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Animal Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Animal Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zoetis
11.1.1 Zoetis Company Detail
11.1.2 Zoetis Business Overview
11.1.3 Zoetis Animal Drugs Introduction
11.1.4 Zoetis Revenue in Animal Drugs Business (2019-2024)
11.1.5 Zoetis Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Detail
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Animal Drugs Introduction
11.2.4 Boehringer Ingelheim Revenue in Animal Drugs Business (2019-2024)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Merck Animal Health
11.3.1 Merck Animal Health Company Detail
11.3.2 Merck Animal Health Business Overview
11.3.3 Merck Animal Health Animal Drugs Introduction
11.3.4 Merck Animal Health Revenue in Animal Drugs Business (2019-2024)
11.3.5 Merck Animal Health Recent Development
11.4 Elanco
11.4.1 Elanco Company Detail
11.4.2 Elanco Business Overview
11.4.3 Elanco Animal Drugs Introduction
11.4.4 Elanco Revenue in Animal Drugs Business (2019-2024)
11.4.5 Elanco Recent Development
11.5 Bayer Animal Health
11.5.1 Bayer Animal Health Company Detail
11.5.2 Bayer Animal Health Business Overview
11.5.3 Bayer Animal Health Animal Drugs Introduction
11.5.4 Bayer Animal Health Revenue in Animal Drugs Business (2019-2024)
11.5.5 Bayer Animal Health Recent Development
11.6 Ceva Animal Health
11.6.1 Ceva Animal Health Company Detail
11.6.2 Ceva Animal Health Business Overview
11.6.3 Ceva Animal Health Animal Drugs Introduction
11.6.4 Ceva Animal Health Revenue in Animal Drugs Business (2019-2024)
11.6.5 Ceva Animal Health Recent Development
11.7 Virbac
11.7.1 Virbac Company Detail
11.7.2 Virbac Business Overview
11.7.3 Virbac Animal Drugs Introduction
11.7.4 Virbac Revenue in Animal Drugs Business (2019-2024)
11.7.5 Virbac Recent Development
11.8 Dechra
11.8.1 Dechra Company Detail
11.8.2 Dechra Business Overview
11.8.3 Dechra Animal Drugs Introduction
11.8.4 Dechra Revenue in Animal Drugs Business (2019-2024)
11.8.5 Dechra Recent Development
11.9 Phibro
11.9.1 Phibro Company Detail
11.9.2 Phibro Business Overview
11.9.3 Phibro Animal Drugs Introduction
11.9.4 Phibro Revenue in Animal Drugs Business (2019-2024)
11.9.5 Phibro Recent Development
11.10 Vetoquinol
11.10.1 Vetoquinol Company Detail
11.10.2 Vetoquinol Business Overview
11.10.3 Vetoquinol Animal Drugs Introduction
11.10.4 Vetoquinol Revenue in Animal Drugs Business (2019-2024)
11.10.5 Vetoquinol Recent Development
11.11 Ouro Fino Saude
11.11.1 Ouro Fino Saude Company Detail
11.11.2 Ouro Fino Saude Business Overview
11.11.3 Ouro Fino Saude Animal Drugs Introduction
11.11.4 Ouro Fino Saude Revenue in Animal Drugs Business (2019-2024)
11.11.5 Ouro Fino Saude Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
